Insider · CIK 0001690298

Curran Terrie

Reports to the SEC for 4 companies · WESTLAKE VILLAGE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001690298

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-27	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−11.1K sh	$25.03	−$279K	23,526
2026-08-27	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−27.1K sh	$25.03	−$677K	23,526
2026-08-27	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27.1K sh	$8.63	+$233K	50,578
2026-08-27	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2026-08-27	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−27.1K sh	—	—	0
2026-08-27	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	$7.51	+$83.7K	34,674
2026-08-20	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,072 sh	$7.51	+$8,050.72	24,598
2026-08-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−1,072 sh	$26.04	−$27.9K	23,526
2026-08-20	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,072 sh	—	—	11,148
2026-06-05	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+5,778 sh	—	—	23,526
2026-06-05	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,667
2025-06-12	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,568
2025-06-12	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+7,609 sh	—	—	17,748
2025-02-27	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and Chief Executive	AAward	+343K sh	—	—	342,500
2025-01-21	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−19.1K sh	$6.59	−$126K	360,465
2024-11-11	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−8,687 sh	$10.85	−$94.2K	10,139
2024-07-15	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−33.8K sh	$11.72	−$397K	377,734
2024-06-14	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	18,826
2024-06-14	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.1K sh	—	—	27,052
2024-03-22	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−16.9K sh	$9.11	−$154K	410,784
2024-01-18	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and Chief Executive	AAward	+475K sh	—	—	475,000
2023-11-01	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+37.5K sh	—	—	427,171
2023-07-14	PHATPhathom Pharmaceuticals, Inc. · Stock OptionD Disposition to Issuer	Director, President and Chief Executive	DDisposition to Issuer	−225K sh	—	—	0
2023-07-14	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+200K sh	—	—	389,671
2023-07-14	PHATPhathom Pharmaceuticals, Inc. · Stock OptionD Disposition to Issuer	Director, President and Chief Executive	DDisposition to Issuer	−175K sh	—	—	0
2023-05-31	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.2K sh	—	—	12,220
2023-05-31	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,375 sh	—	—	8,687
2023-04-06	PHATPhathom Pharmaceuticals, Inc.P Purchase	Director, President and Chief Executive	PPurchase	+12.9K sh	$7.82	+$101K	188,290
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,250 sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.8K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.2K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Director	DDisposition to Issuer	−3,673 sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.1K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.6K sh	—	—	0
2023-03-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−1,436 sh	$8.54	−$12.3K	175,371
2023-01-20	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−5,821 sh	$8.20	−$47.7K	176,807
2023-01-19	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and Chief Executive	AAward	+163K sh	—	—	162,500
2023-01-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+97.5K sh	—	—	182,628
2022-11-21	PHATPhathom Pharmaceuticals, Inc.S Sale	Director, President and Chief Executive	SSale	−1,526 sh	$9.60	−$14.6K	83,720
2022-10-26	Myovant Sciences Ltd.A Award	Director	AAward	+9,859 sh	—	—	9,859
2022-09-01	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+7,500 sh	—	—	85,246
2022-06-01	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,796
2022-06-01	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,312 sh	—	—	4,312
2022-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+12K sh	—	—	76,595
2022-05-13	PHATPhathom Pharmaceuticals, Inc.P Purchase	Director, President and Chief Executive	PPurchase	+20.5K sh	$7.41	+$152K	64,595
2022-01-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and Chief Executive	AAward	+41.3K sh	—	—	44,095
2022-01-19	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and Chief Executive	AAward	+206K sh	—	—	206,250
2021-11-05	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,096

Recent filings

Accepted (ET)
Aug 284
Curran Terrie0001628280-26-059444
SEC(opens sec.gov)
Aug 244
Curran Terrie0001628280-26-058648
SEC(opens sec.gov)
Jun 94
Curran Terrie0001628280-26-042042
SEC(opens sec.gov)
Jun 164
Curran Terrie0002065881-25-000025
SEC(opens sec.gov)
Mar 34
Curran Terrie0000950170-25-031048
SEC(opens sec.gov)
Jan 234
Curran Terrie0000950170-25-008348
SEC(opens sec.gov)
Nov 134
Curran Terrie0001787306-24-000155
SEC(opens sec.gov)
Jul 174
Curran Terrie0000950170-24-084179
SEC(opens sec.gov)
Jun 184
Curran Terrie0001787306-24-000103
SEC(opens sec.gov)
Mar 264
Curran Terrie0000950170-24-036398
SEC(opens sec.gov)

Companies

Address

C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300

WESTLAKE VILLAGE, CA, 91361